Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
Stefan D. Anker(German Centre for Cardiovascular Research), Giuseppe Rosano(Vita-Salute San Raffaele University), Burkert Pieske(German Centre for Cardiovascular Research), Gianluigi Savarese(Karolinska Institutet), Antoni Bayés‐Genís(Universitat Autònoma de Barcelona), John R. Teerlink(San Francisco VA Medical Center), Piotr Ponikowski(Wroclaw Medical University), Amina Rakisheva(Almaty Management University), Gerasimos Filippatos(National and Kapodistrian University of Athens), Maurizio Volterrani, Mariantonietta Cicoira(Azienda Ospedaliera Universitaria Integrata Verona), Stephan von Haehling(University of Göttingen), José Ramón González‐Juanatey(Universidade de Santiago de Compostela), Enrico Agabiti‐Rosei(Medica (Italy)), Andrew J.S. Coats(IRCCS Ospedale San Raffaele), Johann Bauersachs(Medizinische Hochschule Hannover), Ovidiu Chioncel, Konstantinos Tsioufis(Hippocration General Hospital), William T. Abraham(Lung Institute), Lars H. Lund(Karolinska University Hospital), Francesco Cosentino(University of Zurich), Marianna Adamo, Ewa A. Jankowska, Brenda Moura, Vijay Chopra(Medanta The Medicity), Petar Seferović, Javed Butler(Emory University), Yuhui Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Shelley Zieroth, Ulf Landmesser(University of Zurich), José Luís Merino(Hospital Universitario La Paz), Wilfried Müllens(Ziekenhuis Oost-Limburg), Carsten Tschöpe(Franklin University), Felicita Andreotti, Jian Zhang(Texas A&M Health Science Center), Muhammad Usman(Dow University of Health Sciences), Markus S. Anker(Berlin-Brandenburger Centrum für Regenerative Therapien), Marco Metra(Surgical Specialties (Canada)), Michael Böhm(Saarland University)
Cited by 187
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
|European Journal of Heart Failure|2016|5.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k